相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors
Timothy A. Yap et al.
CANCER DISCOVERY (2021)
An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence
Eugen Dhimolea et al.
CANCER CELL (2021)
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
Robert Vander Velde et al.
NATURE COMMUNICATIONS (2020)
Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
Peter van Galen et al.
CELL (2019)
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML
Cihangir Duy et al.
CANCER DISCOVERY (2019)
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia
Vindhya Vijay et al.
LEUKEMIA RESEARCH (2019)
Cellular Senescence: Defining a Path Forward
Vassilis Gorgoulis et al.
CELL (2019)
Tumor cell escape from therapy-induced senescence
Tareq Saleh et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-kappa B
Dorthe Aasland et al.
CANCER RESEARCH (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
Ibrahim Aldoss et al.
HAEMATOLOGICA (2018)
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
Anish Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
Ibrahim Aldoss et al.
HAEMATOLOGICA (2018)
Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence
Allison L. Boyd et al.
CANCER CELL (2018)
An intrinsic S/G2 checkpoint enforced by ATR
Joshua C. Saldivar et al.
SCIENCE (2018)
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase
Sarah E. Fordham et al.
BLOOD ADVANCES (2018)
The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration
Birgit Ritschka et al.
GENES & DEVELOPMENT (2017)
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
Liran I. Shlush et al.
NATURE (2017)
The essential kinase ATR: ensuring faithful duplication of a challenging genome
Joshua C. Saldivar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Thomas Farge et al.
CANCER DISCOVERY (2017)
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
Lynh Nguyen et al.
GENES (2017)
Tumor cell senescence response produces aggressive variants
Leixiang Yang et al.
CELL DEATH DISCOVERY (2017)
The enigma of embryonic diapause
Marilyn B. Renfree et al.
DEVELOPMENT (2017)
Unmasking Transcriptional Heterogeneity in Senescent Cells
Alejandra Hernandez-Segura et al.
CURRENT BIOLOGY (2017)
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
Tzu-Chieh Ho et al.
BLOOD (2016)
Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause
Roberta Scognamiglio et al.
CELL (2016)
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Stanley W. K. Ng et al.
NATURE (2016)
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Sheng Li et al.
NATURE MEDICINE (2016)
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence
Priyanka L. Patel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Lluc Mosteiro et al.
SCIENCE (2016)
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 inhibitors in SCLC
Helai P. Mohammad et al.
CANCER CELL (2015)
Lineage-Specific Profiling Delineates the Emergence and Progression of Naive Pluripotency in Mammalian Embryogenesis
Thorsten Boroviak et al.
DEVELOPMENTAL CELL (2015)
Spatial reconstruction of single-cell gene expression data
Rahul Satija et al.
NATURE BIOTECHNOLOGY (2015)
The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4
Chanhee Kang et al.
SCIENCE (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Antonina V. Kurtova et al.
NATURE (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Marco Demaria et al.
DEVELOPMENTAL CELL (2014)
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Claudio Franceschi et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier
Margarida A. Santos et al.
NATURE (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Genomic impact of transient low-dose decitabine treatment on primary AML cells
Jeffery M. Klco et al.
BLOOD (2013)
A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism
Ariel Pribluda et al.
CANCER CELL (2013)
Programmed Cell Senescence during Mammalian Embryonic Development
Daniel Munoz-Espin et al.
CELL (2013)
Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning
Mekayla Storer et al.
CELL (2013)
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta et al.
NATURE CELL BIOLOGY (2013)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
Davis J. McCarthy et al.
NUCLEIC ACIDS RESEARCH (2012)
Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity
Yuchen Chien et al.
GENES & DEVELOPMENT (2011)
Escape from p21-mediated Oncogene-induced Senescence Leads to Cell Dedifferentiation and Dependence on Anti-apoptotic Bcl-xL and MCL1 Proteins
Sophie de Carne Trecesson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Therapeutic Advances in Acute Myeloid Leukemia
Alan Burnett et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
Jean-Damien Charrier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML
H. J. M. de Jonge et al.
LEUKEMIA (2011)
Stem cell gene expression programs influence clinical outcome in human leukemia
Kolja Eppert et al.
NATURE MEDICINE (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing
Joon-Il Jun et al.
NATURE CELL BIOLOGY (2010)
MYC as a regulator of ribosome biogenesis and protein synthesis
Jan van Riggelen et al.
NATURE REVIEWS CANCER (2010)
Protocols to detect senescence-associated beta-galactosidase (SA-beta gal) activity, a biomarker of senescent cells in culture and in vivo
Florence Debacq-Chainiaux et al.
NATURE PROTOCOLS (2009)
Senescence-messaging secretome: SMS-ing cellular stress
Thomas Kuilman et al.
NATURE REVIEWS CANCER (2009)
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network
Thomas Kuilman et al.
CELL (2008)
Critical pathways in cellular senescence and immortalization revealed by gene expression profiling
A. L. Fridman et al.
ONCOGENE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers
RS Roberson et al.
CANCER RESEARCH (2005)
Mechanisms controlling pathogenesis and survival of leukemic stem cells
CT Jordan et al.
ONCOGENE (2004)
Embryonic diapause and its regulation
FL Lopes et al.
REPRODUCTION (2004)
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
M Narita et al.
CELL (2003)
Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion
CL Olsen et al.
ONCOGENE (2002)
Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine
J Braess et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
